Distribution of EV71 receptors SCARB2 and PSGL-1 in human tissues

Virus Research

Volumn 190, Issue , 2014, Pages 40-52

  Jiao, Xiao Yang ^a,b   Guo, Li ^a   Huang, Dong Yang ^a   Chang, Xiao Lan ^a   Qiu, Qian Cheng ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

EV71 virus; HFMD; PSGL 1; SCARB2

Indexed keywords

P SELECTIN GLYCOPROTEIN LIGAND 1; PROTEIN; SCARB2 PROTEIN; UNCLASSIFIED DRUG; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MEMBRANE PROTEIN; P-SELECTIN LIGAND PROTEIN; SCARB2 PROTEIN, HUMAN; SCAVENGER RECEPTOR; VIRUS RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD VESSEL; BRAIN TISSUE; BRONCHUS MUCOSA; CONTROLLED STUDY; ENTEROVIRUS 71; ESOPHAGUS MUCOSA; FEMALE; GASTROINTESTINAL TRACT; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; LAMINA PROPRIA; LUNG ALVEOLUS CELL; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALIVARY GLAND; STOMACH FUNDUS; STOMACH MUCOSA; BRAIN; CELL LINE; COMPARATIVE STUDY; ENTEROVIRUS; ENTEROVIRUS INFECTION; GENETICS; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN; CELL LINE; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LUNG; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; YOUNG ADULT;

EID: 84906074786     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.05.007     Document Type: Article

References (40)

1. Arita M., Shimizu H., Nagata N., Ami Y., Suzaki Y., Sata T., Iwasaki T., Miyamura T. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 2005, 86(Pt 5):1391-1401.
2. Bek E.J., McMinn P.C. The pathogenesis and prevention of encephalitis due to human enterovirus 71. Curr. Infect. Dis. Rep. 2012, 14(4):397-407.
3. Bible J.M., Pantelidis P., Chan P.K., Tong C.Y. Genetic evolution of enterovirus 71: epidemiological and pathological implications. Rev. Med. Virol. 2007, 17(6):371-379.
4. Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., Jegathesan M., Anderson L.J. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin. Infect. Dis. 2000, 31(3):678-683.
5. Eskelinen E.L., Tanaka Y., Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003, 13(3):137-145.
6. Flint M., Tscherne D.M. Cellular receptors and HCV entry. Methods Mol. Biol. 2009, 510:265-277.
7. He Y., Ong K.C., Gao Z., Zhao X., Anderson V.M., McNutt M.A., Wong K.T., Lu M. Tonsillar crypt epithelium is an important extra-central nervous system site for viral replication in EV71 encephalomyelitis. Am. J. Pathol. 2014, 184(3):714-720.
8. Khong W.X., Yan B., Yeo H., Tan E.L., Lee J.J., Ng J.K., Chow V.T., Alonso S. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 2012, 86(4):2121-2131.
9. Kuronita T., Eskelinen E.L., Fujita H., Saftig P., Himeno M., Tanaka Y. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J. Cell Sci. 2002, 115(Pt 21):4117-4131.
10. Laszik Z., Jansen P.J., Cummings R.D., Tedder T.F., McEver R.P., Moore K.L. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 1996, 88(8):3010-3021.
11. Li X., Fan P., Jin J., Su W., An D., Xu L., Sun S., Zhang Y., Meng X., Gao F., Kong W., Jiang C. Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol. J. 2013, 10(1):250.
12. Lin T.Y., Hsia S.H., Huang Y.C., Wu C.T., Chang L.Y. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 2003, 36(3):269-274.
13. Lin Y.W., Lin H.Y., Tsou Y.L., Chitra E., Hsiao K.N., Shao H.Y., Liu C.C., Sia C., Chong P., Chow Y.H. Human SCARB2-mediated entry and endocytosis of EV71. PLoS One 2012, 7(1):e30507.
14. Liu C.C., Tseng H.W., Wang S.M., Wang J.R., Su I.J. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J. Clin. Virol. 2000, 17(1):23-30.
15. Liu J., Dong W., Quan X., Ma C., Qin C., Zhang L. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch. Virol. 2012, 157(3):539-543.
16. Liu L., Zhao H., Zhang Y., Wang J., Che Y., Dong C., Zhang X., Na R., Shi H., Jiang L., Wang L., Xie Z., Cui P., Xiong X., Liao Y., Zhao S., Gao J., Tang D., Li Q. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology 2011, 412(1):91-100.
17. McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2002, 26(1):91-107.
18. Mendelsohn C.L., Wimmer E., Racaniello V.R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989, 56(5):855-865.
19. Nathanson N. The pathogenesis of poliomyelitis: what we don't know. Adv. Virus Res. 2008, 71:1-50.
20. Nishimura Y., Lee H., Hafenstein S., Kataoka C., Wakita T., Bergelson J.M., Shimizu H. Enterovirus 71 binding to PSGL-1 on leukocytes: VP 1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013, 9(7):e1003511.
21. Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009, 15(7):794-797.
22. Nishimura Y., Wakita T., Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 2010, 6(11):e1001174.
23. Nolan M.A., Craig M.E., Lahra M.M., Rawlinson W.D., Prager P.C., Williams G.D., Bye A.M., Andrews P.I. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 2003, 60(10):1651-1656.
24. Sato C., Shikata K., Hirota D., Sasaki M., Nishishita S., Miyamoto S., Kodera R., Ogawa D., Tone A., Kataoka H.U., Wada J., Kajitani N., Makino H. P-selectin glycoprotein ligand-1 deficiency is protective against obesity-related insulin resistance. Diabetes 2011, 60(1):189-199.
25. Shen W.C., Chiu H.H., Chow K.C., Tsai C.H. MR imaging findings of enteroviral encephaloymelitis: an outbreak in Taiwan. Am. J. Neuroradiol. 1999, 20(10):1889-1895.
26. Shieh W.J., Jung S.M., Hsueh C., Kuo T.T., Mounts A., Parashar U., Yang C.F., Guarner J., Ksiazek T.G., Dawson J., Goldsmith C., Chang G.J., Oberste S.M., Pallansch M.A., Anderson L.J., Zaki S.R. Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. Emerg. Infect. Dis. 2001, 7(1):146-148.
27. Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010, 10(11):778-790.
28. Verboon-Maciolek M.A., Utrecht F.G., Cowan F., Govaert P., van Loon A.M., de Vries L.S. White matter damage in neonatal enterovirus meningoencephalitis. Neurology 2008, 71(7):536.
29. Weng K.F., Chen L.L., Huang P.N., Shih S.R. Neural pathogenesis of enterovirus 71 infection. Microbes Infect. 2010, 12(7):505-510.
30. Wong K.T., Munisamy B., Ong K.C., Kojima H., Noriyo N., Chua K.B., Ong B.B., Nagashima K. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J. Neuropathol. Exp. Neurol. 2008, 67(2):162-169.
31. Xu W., Liu C.F., Yan L., Li J.J., Wang L.J., Qi Y., Cheng R.B., Xiong X.Y. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol. J. 2012, 9(1):8.
32. Yamayoshi S., Iizuka S., Yamashita T., Minagawa H., Mizuta K., Okamoto M., Nishimura H., Sanjoh K., Katsushima N., Itagaki T., Nagai Y., Fujii K., Koike S. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J. Virol. 2012, 86(10):5686-5696.
33. Yamayoshi S., Koike S. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J. Virol. 2011, 85(10):4937-4946.
34. Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009, 15(7):798-801.
35. Yang B., Chuang H., Yang K.D. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 2009, 6:141.
36. Yang F., Ren L., Xiong Z., Li J., Xiao Y., Zhao R., He Y., Bu G., Zhou S., Wang J., Qi J. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 2009, 47(7):2351-2352.
37. Yi L., Lu J., Kung H.F., He M.L. The virology and developments toward control of human enterovirus 71. Crit. Rev. Microbiol. 2011, 37(4):313-327.
38. Yu H., Chen W., Chang H., Tang R., Zhao J., Gan L., Liu B., Chen J., Wang M. Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008. Virus Genes 2010, 41(1):1-4.
39. Zhang Y., Cui W., Liu L., Wang J., Zhao H., Liao Y., Na R., Dong C., Wang L., Xie Z., Gao J., Cui P., Zhang X., Li Q. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Invest. 2011, 91(9):1337-1350.
40. Zhang Y.C., Jiang S.W., Gu W.Z., Hu A.R., Lu C.T., Liang X.Y., Hu Y.R., Zhu D.D., Xie L. Clinicopathologic features and molecular analysis of enterovirus 71 infection: report of an autopsy case from the epidemic of hand, foot and mouth disease in China. Pathol. Int. 2012, 62(8):565-570.